Literature DB >> 24336652

Conditions that promote primary human skeletal myoblast culture and muscle differentiation in vitro.

Cindy S Cheng1, Yasser El-Abd, Khanh Bui, Young-Eun Hyun, Rebecca Harbuck Hughes, William E Kraus, George A Truskey.   

Abstract

Conditions under which skeletal myoblasts are cultured in vitro are critical to growth and differentiation of these cells into mature skeletal myofibers. We examined several culture conditions that promoted human skeletal myoblast (HSkM) culture and examined the effect of microRNAs and mechanical stimulation on differentiation. Culture conditions for HSkM are different from those that enable rapid C2C12 myoblast differentiation. Culture on a growth factor-reduced Matrigel (GFR-MG)-coated surface in 2% equine serum-supplemented differentiation medium to promote HSkM differentiation under static conditions was compared with culture conditions used for C2C12 cell differentiation. Such conditions led to a >20-fold increase in myogenic miR-1, miR-133a, and miR-206 expression, a >2-fold increase in myogenic transcription factor Mef-2C expression, and an increase in sarcomeric α-actinin protein. Imposing ±10% cyclic stretch at 0.5 Hz for 1 h followed by 5 h of rest over 2 wk produced a >20% increase in miR-1, miR-133a, and miR-206 expression in 8% equine serum and a >35% decrease in 2% equine serum relative to static conditions. HSkM differentiation was accelerated in vitro by inhibition of proliferation-promoting miR-133a: immunofluorescence for sarcomeric α-actinin exhibited accelerated development of striations compared with the corresponding negative control, and Western blotting showed 30% more α-actinin at day 6 postdifferentiation. This study showed that 100 μg/ml GFR-MG coating and 2% equine serum-supplemented differentiation medium enhanced HSkM differentiation and myogenic miR expression and that addition of antisense miR-133a alone can accelerate primary human skeletal muscle differentiation in vitro.

Entities:  

Keywords:  differentiation; microRNA; myogenesis; skeletal muscle; tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 24336652      PMCID: PMC3919982          DOI: 10.1152/ajpcell.00179.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  45 in total

Review 1.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

2.  Morphology and ultrastructure of differentiating three-dimensional mammalian skeletal muscle in a collagen gel.

Authors:  Caroline Rhim; Dorothy A Lowell; Mary C Reedy; Dorothy H Slentz; Sarah J Zhang; William E Kraus; George A Truskey
Journal:  Muscle Nerve       Date:  2007-07       Impact factor: 3.217

3.  Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.

Authors:  Jing Zhang; Shu Kan; Brian Huang; Zhenyue Hao; Tak W Mak; Qing Zhong
Journal:  Genes Dev       Date:  2011-10-20       Impact factor: 11.361

4.  Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue.

Authors:  Zeeshan H Syedain; Justin S Weinberg; Robert T Tranquillo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

5.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Authors:  Ning Liu; Svetlana Bezprozvannaya; John M Shelton; Madlyn I Frisard; Matthew W Hulver; Ryan P McMillan; Yaru Wu; Kevin A Voelker; Robert W Grange; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

6.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

7.  Effect of serum and mechanical stretch on skeletal alpha-actin gene regulation in cultured primary muscle cells.

Authors:  J A Carson; F W Booth
Journal:  Am J Physiol       Date:  1998-12

8.  Characterization of human myoblast cultures for tissue engineering.

Authors:  Jens Stern-Straeter; Gregor Bran; Frank Riedel; Alexander Sauter; Karl Hörmann; Ulrich Reinhart Goessler
Journal:  Int J Mol Med       Date:  2008-01       Impact factor: 4.101

9.  Stretch-induced nitric oxide modulates mechanical properties of skeletal muscle cells.

Authors:  Jingying Sarah Zhang; William E Kraus; George A Truskey
Journal:  Am J Physiol Cell Physiol       Date:  2004-03-24       Impact factor: 4.249

10.  Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markers.

Authors:  Andreina Baj; Alessia A Bettaccini; Rosario Casalone; Andrea Sala; Paolo Cherubino; Antonio Q Toniolo
Journal:  J Transl Med       Date:  2005-05-12       Impact factor: 5.531

View more
  21 in total

1.  Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered Myobundles.

Authors:  Brittany N J Davis; Jeffrey W Santoso; Michaela J Walker; Catherine E Oliver; Michael M Cunningham; Christian A Boehm; Danielle Dawes; Samantha L Lasater; Kim Huffman; William E Kraus; George A Truskey
Journal:  Ann Biomed Eng       Date:  2019-04-08       Impact factor: 3.934

2.  Human, Tissue-Engineered, Skeletal Muscle Myobundles to Measure Oxygen Uptake and Assess Mitochondrial Toxicity.

Authors:  Brittany N J Davis; Jeffrey W Santoso; Michaela J Walker; Cindy S Cheng; Timothy R Koves; William E Kraus; George A Truskey
Journal:  Tissue Eng Part C Methods       Date:  2017-03-24       Impact factor: 3.056

3.  Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.

Authors:  Cindy S Cheng; Lydia Ran; Nenad Bursac; William E Kraus; George A Truskey
Journal:  Tissue Eng Part A       Date:  2016-04       Impact factor: 3.845

4.  Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.

Authors:  Blas A Guigni; Jos van der Velden; C Matthew Kinsey; James A Carson; Michael J Toth
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-05       Impact factor: 4.310

5.  High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts.

Authors:  William D Klaren; Ivan Rusyn
Journal:  Assay Drug Dev Technol       Date:  2018-08-02       Impact factor: 1.738

6.  Isolation and Purification of Satellite Cells for Skeletal Muscle Tissue Engineering.

Authors:  Brian C Syverud; Jonah D Lee; Keith W VanDusen; Lisa M Larkin
Journal:  J Regen Med       Date:  2014

Review 7.  Physiology and metabolism of tissue-engineered skeletal muscle.

Authors:  Cindy S Cheng; Brittany N J Davis; Lauran Madden; Nenad Bursac; George A Truskey
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-09

8.  Engineering skeletal muscle tissues with advanced maturity improves synapse formation with human induced pluripotent stem cell-derived motor neurons.

Authors:  Jeffrey W Santoso; Xiling Li; Divya Gupta; Gio C Suh; Eric Hendricks; Shaoyu Lin; Sarah Perry; Justin K Ichida; Dion Dickman; Megan L McCain
Journal:  APL Bioeng       Date:  2021-07-13

Review 9.  Bioengineering Outlook on Cultivated Meat Production.

Authors:  Ivana Pajčin; Teodora Knežić; Ivana Savic Azoulay; Vanja Vlajkov; Mila Djisalov; Ljiljana Janjušević; Jovana Grahovac; Ivana Gadjanski
Journal:  Micromachines (Basel)       Date:  2022-02-28       Impact factor: 2.891

10.  A multiplexed in vitro assay system for evaluating human skeletal muscle functionality in response to drug treatment.

Authors:  Sarah A Najjar; Alexander S T Smith; Christopher J Long; Christopher W McAleer; Yunqing Cai; Balaji Srinivasan; Candace Martin; Herman H Vandenburgh; James J Hickman
Journal:  Biotechnol Bioeng       Date:  2019-12-13       Impact factor: 4.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.